Highlights from
SLEEP 2025
We had a great time at SLEEP 2025 sharing our newest solutions to help your patients get started — and stay engaged — with PAP therapy, while also boosting operational efficiency.
Innovative diagnostics for better patient care
We’re making it easier to diagnose and treat obstructive sleep apnea (OSA) with simple, connected tools that help you save time and deliver better care.
Somnoware
Somnoware is a cloud-based, agnostic platform that integrates disparate devices and data from third-party applications into one platform for streamlined sleep apnea and respiratory diagnostic testing and a smoother operational workflow.
NightOwl
NightOwl™ is our fully disposable home sleep apnea test now available across the US. NightOwl offers a simplified sleep testing experience for you and your patients.
EasyCare Tx 2
The EasyCare Tx 2 titration software bundle, compatible with the AirCurve™ 11 VPAP™ Tx device, is part of our comprehensive sleep lab solution that treats a range of patients, designed to support comfortable, uninterrupted sleep for effective titration.
CPAP therapy can save lives for those living with sleep apnea
A groundbreaking study was presented at SLEEP 2025 and published in The Lancet Respiratory Medicine journal, showing that CPAP therapy isn’t just good for health — it can prolong the lives of those living with sleep apnea.1
Analyzing data from over one million patients worldwide, the study found:1
- People with OSA who use CPAP had a 37% lower risk of death from any cause
- For people with OSA, CPAP reduced the risk for cardiovascular-related death by 55%
- The more consistently CPAP is used, the greater the survival benefit for people with OSA
This research underscores the life-changing and life-extending impact of the therapy we support every day at Resmed.
Abstracts presented at
SLEEP 2025:
The Resmed Health Research team presented nine abstracts at SLEEP 2025, sharing significant contributions to the sleep and respiratory care fields through health economic outcomes research, person-centered research, real-world evidence and clinical research. Key highlights include:
- Use of PAP lowers risk of cardiovascular related events: Patients who are consistently using PAP therapy for two years have a 22% lower risk of having a serious cardiovascular-related event than patients who are not using their PAP device. View Abstract
- Gender disparity in growing OSA prevalence: A disproportionately growing burden of OSA is estimated among females compared to males. View Abstract
- Use of PAP improves quality of life: Patients with OSA and on PAP therapy reported significant, perceived improvements in related co-morbidities, symptoms, and quality of life following PAP initiation — and many of these benefits are realised within 90 days and persist/improve over time. View Abstract
- Role of the primary care physician in sleep care: This study highlights three areas where PCPs can enhance their support of patients with OSA — PCP awareness around diversity of OSA symptoms (including gender-specific symptoms), care coordination, and patient-centered support. View Abstract
Additional evidence presented includes:
- Importance of treating patients with COMISA: Patients with COMISA have more conditions and use more healthcare resources than patients with OSA or insomnia alone. View Abstract
- Real-world look at CPAP-treated people with OSA: From an OSA population that goes on to be treated with PAP therapy, nearly half were women, with average blood pressure readings indicative of stage 1 hypertension and average A1c measurements indicative of prediabetes, and 90% of patients were managing one other chronic condition in addition to OSA. View Abstract
- OSA 2050 burden with a focus on older adults: The prevalence of OSA in older adults is expected to rise significantly through 2050, with the most pronounced increase among older females. View Abstract
- Wearable devices — data sharing and confidence: Most wearable users are confident in the accuracy of their data — but few (only 1 in 6) share their data with a healthcare provider to aid care discussions. View Abstract
- Impact of PAP therapy on relationship quality & patient journey experiences: This study highlights key patient-reported experiences throughout the sleep apnea journey, informing where care pathways could be optimized to enhance overall patient satisfaction. View Abstract
Let's connect
Contact us to connect with a sales representative.
References:
- Source: Benjafield AV, et al. Lancet Respir Med. 2025 Mar 18: S2213-2600.